TEM classification (aortic dissection)
One-liner
Adds entry tear location and malperfusion status to Stanford (incl. non-A non-B). Use TEM alongside Stanford to convey management-relevant detail.
Components
T — Type (proximal involvement)
- A: Ascending aorta involved (± arch/descending)
- non-A non-B: Arch (± descending) with ascending spared
- B: Descending aorta only (origin distal to left subclavian artery)
E — Entry (primary tear site)
- E0: No entry identified
- E1: Root/ascending aorta
- E2: Arch
- E3: Descending aorta (distal to arch)
M — Malperfusion (end-organ ischaemia)
- M0: None
- M1: Coronary
- M2: Supra-aortic branches (e.g., carotid/vertebral)
- M3: Spinal cord / visceral / renal / limb
Tip: State the organ if known (e.g., M2 carotid, M3 renal). Some centres add “+” for clinical malperfusion (e.g., M2+).
How to read
- Confirm ECG-gating/phase, contrast timing, and op note/TTE (transthoracic echo) if available
- Identify intimal flap, true vs false lumen, entry tear (E1–E3 or E0)
- Map branch-vessel origins from true vs false lumen
- Screen for malperfusion (bowel/renal hypoperfusion, carotid signs, spinal cord risk) and pericardial haemorrhage
Report skeleton (cardio-CT)
- Indication/technique: gating, phase, contrast, key limitations
- Aorta: type (T), dissection/IMH/PAU, pericardium
- Entry: E0/E1/E2/E3 (location); secondary tears if present
- Branch vessels: origin (true/false), stenosis/occlusion
- Malperfusion: M0–M3 + organ(s); clinical “+” if applicable
- Impression: “Aortic dissection: T __ / E__ / M__ (Stanford __). So-what/action: __. Confidence: __ because __.”
Examples
- T B / E3 / M0 → Stanford B; entry descending; no malperfusion
- T A / E2 / M0 → Ascending involved (Type A) with arch entry
- T non-A non-B / E2 / M2+ (carotid) → Arch-entry dissection; clinical neuro signs
- T B / E3 / M3 (renal, limb) → Descending entry; renal + limb malperfusion
Pitfalls & “uncertain” lines
- Motion/poor opacification: “Uncertain—because motion/contrast timing limits assessment of entry/malperfusion.”
- Arch-only disease: call non-A non-B explicitly; management varies.
- Do not infer malperfusion from lumen patency alone—look for end-organ effects; add “+” only with clinical evidence.
Quick checklist (before read-out)
- Stanford A vs B decided?
- Entry site labelled (E0–E3)?
- End-organ status screened and stated (M0–M3 ± organ, “+” if clinical)?
- Pericardium checked? Branch-vessels mapped? Grafts/stents noted?